STA
VBIV

Summit Trail Advisors’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Summit Trail Advisors’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2
Closed – – 1754
2017
Q4 		$0 Buy
+2
New +$246 ﹤0.01% 2113

Other funds holding VBIV

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Summit Trail Advisors's VBIV Position: Q1 2018 in Review

Summit Trail Advisors sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q1 2018, closing a stake of 2 shares.

Summit Trail Advisors first reported a position in VBIV in Q4 2017 and held it in 1 quarter. The position peaked at $0 in Q4 2017. 60 funds tracked by Wall St. Rank hold VBIV as of Q1 2018.

  • Summit Trail Advisors reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q1 2018 after selling out during the quarter.
  • Summit Trail Advisors sold 2 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q1 2018.
  • Summit Trail Advisors first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2017 and held it in 1 quarter.
  • Summit Trail Advisors's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $0 in Q4 2017.
  • 60 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q1 2018.

Based on Summit Trail Advisors's 13F filing for Q1 2018, filed 21 May 2018.